A dozen volunteers with severe type 1 diabetes showed clear improvements in their condition 12 months after receiving a ...

The findings, published on June 24 in Cell Stem Cell, could allow physicians to treat more patients with fewer cells. In type 1 diabetes, autoimmune cells attack the pancreatic islets, destroying ...

Groundbreaking First-in-Human Study Establishes Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression ...

Lead amylin receptor agonist engineered antibody significantly reduced acute food intake in a mouse model of obesity, ...

·Evidence of islet autoimmunity (e.g., islet cell [ICA] 512 or IA-2, GAD, and insulin autoantibodies) · Evidence of ß-cell secretory capacity (e.g., C-peptide levels) after 1 year, if diagnosis ...

One-year results from the company's FORWARD-101 trial of islet cell therapy zimislecel (also known as VX-880) showed that all ...

Two biomarker tests -- one for blood and the other for stool -- are mainstays in the treatment of inflammatory bowel disease ...

Sanofi's rash of dealmaking has continued with a $2.5 billion tie-up with Chinese cancer immunotherapy biotech Adagene, focused on developing a new generation of safer antibody-based therapies.

前言2025年7月12日至15日，第107 届美国内分泌协会年会（ENDO ...